Literature DB >> 30001512

Alzheimer's Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection.

William A Eimer1, Deepak Kumar Vijaya Kumar1, Nanda Kumar Navalpur Shanmugam1, Alex S Rodriguez1, Teryn Mitchell1, Kevin J Washicosky1, Bence György2, Xandra O Breakefield2, Rudolph E Tanzi3, Robert D Moir4.   

Abstract

Amyloid-β peptide (Aβ) fibrilization and deposition as β-amyloid are hallmarks of Alzheimer's disease (AD) pathology. We recently reported Aβ is an innate immune protein that protects against fungal and bacterial infections. Fibrilization pathways mediate Aβ antimicrobial activities. Thus, infection can seed and dramatically accelerate β-amyloid deposition. Here, we show Aβ oligomers bind herpesvirus surface glycoproteins, accelerating β-amyloid deposition and leading to protective viral entrapment activity in 5XFAD mouse and 3D human neural cell culture infection models against neurotropic herpes simplex virus 1 (HSV1) and human herpesvirus 6A and B. Herpesviridae are linked to AD, but it has been unclear how viruses may induce β-amyloidosis in brain. These data support the notion that Aβ might play a protective role in CNS innate immunity, and suggest an AD etiological mechanism in which herpesviridae infection may directly promote Aβ amyloidosis.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; amyloid-β; antimicrobial peptide; herpes simplex virus 1; herpesviridae; herpesvirus glycoprotein; human herpesvirus 6; infection; oligomers; β-amyloid peptide

Mesh:

Substances:

Year:  2018        PMID: 30001512      PMCID: PMC6075814          DOI: 10.1016/j.neuron.2018.06.030

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  58 in total

1.  Integrating reptilian herpesviruses into the family herpesviridae.

Authors:  Duncan J McGeoch; Derek Gatherer
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Herpes simplex virus type 1 in brain and risk of Alzheimer's disease.

Authors:  R F Itzhaki; W R Lin; D Shang; G K Wilcock; B Faragher; G A Jamieson
Journal:  Lancet       Date:  1997-01-25       Impact factor: 79.321

Review 3.  Human herpesvirus 6 and the nervous system.

Authors:  Joshua A Hill; Nagagopal Venna
Journal:  Handb Clin Neurol       Date:  2014

Review 4.  Innate immunity in Alzheimer's disease.

Authors:  Michael T Heneka; Douglas T Golenbock; Eicke Latz
Journal:  Nat Immunol       Date:  2015-03       Impact factor: 25.606

5.  The structure of human beta-defensin-2 shows evidence of higher order oligomerization.

Authors:  D M Hoover; K R Rajashankar; R Blumenthal; A Puri; J J Oppenheim; O Chertov; J Lubkowski
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

6.  Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes.

Authors:  Friedrich Paulsen; Thomas Pufe; Lenard Conradi; Deike Varoga; Michael Tsokos; Jann Papendieck; Wolf Petersen
Journal:  J Pathol       Date:  2002-11       Impact factor: 7.996

7.  β-Amyloid peptides display protective activity against the human Alzheimer's disease-associated herpes simplex virus-1.

Authors:  Karine Bourgade; Hugo Garneau; Geneviève Giroux; Aurélie Y Le Page; Christian Bocti; Gilles Dupuis; Eric H Frost; Tamàs Fülöp
Journal:  Biogerontology       Date:  2014-11-07       Impact factor: 4.277

Review 8.  Human herpesvirus 6: An emerging pathogen.

Authors:  G Campadelli-Fiume; P Mirandola; L Menotti
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

9.  Amyloidosis of seminal vesicles and ejaculatory ducts: a histologic analysis of 21 cases among 447 prostatectomy specimens.

Authors:  Keun Hong Kee; Mi Ja Lee; Steve S Shen; Jae Hee Suh; Ok-Jun Lee; Hyun Y Cho; Alberto G Ayala; Jae Y Ro
Journal:  Ann Diagn Pathol       Date:  2008-04-18       Impact factor: 2.090

10.  Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model.

Authors:  Karine Bourgade; Aurélie Le Page; Christian Bocti; Jacek M Witkowski; Gilles Dupuis; Eric H Frost; Tamás Fülöp
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

View more
  151 in total

1.  Human Herpesvirus 6 Detection in Alzheimer's Disease Cases and Controls across Multiple Cohorts.

Authors:  Mary Alice Allnutt; Kory Johnson; David A Bennett; Sarah M Connor; Juan C Troncoso; Olga Pletnikova; Marilyn S Albert; Susan M Resnick; Sonja W Scholz; Philip L De Jager; Steven Jacobson
Journal:  Neuron       Date:  2020-01-23       Impact factor: 17.173

2.  Herpes Viruses, Alzheimer's Disease, and Related Dementias: Unifying or Confusing Hypothesis?

Authors:  Avindra Nath
Journal:  Neurotherapeutics       Date:  2019-01       Impact factor: 7.620

Review 3.  'Evolutionary medicine' perspectives on Alzheimer's Disease: Review and new directions.

Authors:  Molly Fox
Journal:  Ageing Res Rev       Date:  2018-07-27       Impact factor: 10.895

Review 4.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.

Authors:  Justin M Long; David M Holtzman
Journal:  Cell       Date:  2019-09-26       Impact factor: 41.582

Review 5.  What is strain in neurodegenerative diseases?

Authors:  Ye Tian; Lanxia Meng; Zhentao Zhang
Journal:  Cell Mol Life Sci       Date:  2019-09-17       Impact factor: 9.261

Review 6.  Can infections trigger alpha-synucleinopathies?

Authors:  Christopher T Tulisiak; Gabriela Mercado; Wouter Peelaerts; Lena Brundin; Patrik Brundin
Journal:  Prog Mol Biol Transl Sci       Date:  2019-07-03       Impact factor: 3.622

Review 7.  Microbiota in cerebrovascular disease: A key player and future therapeutic target.

Authors:  Shuichi Tonomura; Masafumi Ihara; Robert P Friedland
Journal:  J Cereb Blood Flow Metab       Date:  2020-04-20       Impact factor: 6.200

8.  An immune-cell signature marks the brain in Alzheimer's disease.

Authors:  Michael T Heneka
Journal:  Nature       Date:  2020-01       Impact factor: 49.962

9.  Aβ Plaques.

Authors:  Lary C Walker
Journal:  Free Neuropathol       Date:  2020-10-30

Review 10.  Reassessment of Pioglitazone for Alzheimer's Disease.

Authors:  Ann M Saunders; Daniel K Burns; William Kirby Gottschalk
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.